1. Lin, Chengqi, Garruss, Alexander S, Luo, Zhuojuan, Guo, Fengli, Shilatifard, Ali. 2012. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation. In Cell, 152, 144-56. doi:10.1016/j.cell.2012.12.015. https://pubmed.ncbi.nlm.nih.gov/23273992/
2. Kim, Isaac, Kim, Kwang-Soo, Kwon, Ok-Seon, Cha, Hyuk-Jin, Park, Kyung-Soon. 2017. Ell3 stimulates 5-FU resistance in a breast cancer cell line. In Oncology letters, 13, 4173-4179. doi:10.3892/ol.2017.5996. https://pubmed.ncbi.nlm.nih.gov/28588704/
3. Ahn, Hee-Jin, Kim, Gwangil, Park, Kyung-Soon. 2013. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway. In Biochemical and biophysical research communications, 437, 557-64. doi:10.1016/j.bbrc.2013.06.114. https://pubmed.ncbi.nlm.nih.gov/23850691/
4. Ahn, Hee-Jin, Cha, Young, Moon, Seok-Ho, Jung, Jee-Eun, Park, Kyung-Soon. 2012. Ell3 enhances differentiation of mouse embryonic stem cells by regulating epithelial-mesenchymal transition and apoptosis. In PloS one, 7, e40293. doi:10.1371/journal.pone.0040293. https://pubmed.ncbi.nlm.nih.gov/22768269/
5. Zhang, Baojian, Li, Biao, Sun, Chao, Xiao, Yichao, Liu, Qiming. 2021. Identification of key gene modules and pathways of human platelet transcriptome in acute myocardial infarction patients through co-expression network. In American journal of translational research, 13, 3890-3905. doi:. https://pubmed.ncbi.nlm.nih.gov/34017580/
6. Zhu, Shiqi, Xie, Peng, Yang, Yi, Luo, Zhuojuan, Lin, Chengqi. 2025. Maternal ELL3 loss-of-function leads to oocyte aneuploidy and early miscarriage. In Nature structural & molecular biology, 32, 381-392. doi:10.1038/s41594-024-01471-8. https://pubmed.ncbi.nlm.nih.gov/39820605/
智鼠故事 
